{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T04:57:36Z","timestamp":1781067456052,"version":"3.54.1"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472921"],"award-info":[{"award-number":["82472921"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Direct"],"DOI":"10.1186\/s13062-026-00813-4","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T09:25:40Z","timestamp":1777281940000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The role of alternative splicing in gastric cancer"],"prefix":"10.1186","volume":"21","author":[{"given":"Qichen","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyu","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinrui","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yitian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"issue":"3","key":"813_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"36","key":"813_CR2","doi-asserted-by":"publisher","first-page":"5518","DOI":"10.1038\/s41388-021-01963-7","volume":"40","author":"AM Birladeanu","year":"2021","unstructured":"Birladeanu AM, et al. The scaffold protein IQGAP1 links heat-induced stress signals to alternative splicing regulation in gastric cancer cells. Oncogene. 2021;40(36):5518\u201332.","journal-title":"Oncogene"},{"issue":"1","key":"813_CR3","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13046-024-03260-z","volume":"44","author":"G Zhao","year":"2025","unstructured":"Zhao G, et al. NONO regulates m(5)C modification and alternative splicing of PTEN mRNAs to drive gastric cancer progression. J Exp Clin Cancer Res. 2025;44(1):81.","journal-title":"J Exp Clin Cancer Res"},{"issue":"4","key":"813_CR4","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/s41580-022-00545-z","volume":"24","author":"LE Marasco","year":"2023","unstructured":"Marasco LE, Kornblihtt AR. The physiology of alternative splicing. Nat Rev Mol Cell Biol. 2023;24(4):242\u201354.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"813_CR5","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1074\/jbc.270.6.2411","volume":"270","author":"SM Berget","year":"1995","unstructured":"Berget SM. Exon recognition in vertebrate splicing. J Biol Chem. 1995;270(6):2411\u20134.","journal-title":"J Biol Chem"},{"issue":"1","key":"813_CR6","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.cell.2005.07.028","volume":"123","author":"BR Graveley","year":"2005","unstructured":"Graveley BR. Mutually exclusive splicing of the insect Dscam pre-mRNA directed by competing intronic RNA secondary structures. Cell. 2005;123(1):65\u201373.","journal-title":"Cell"},{"key":"813_CR7","doi-asserted-by":"crossref","unstructured":"Kitamura K, Nimura K. Regulation of RNA splicing: aberrant splicing regulation and therapeutic targets in cancer. Cells. 2021;10(4).","DOI":"10.3390\/cells10040923"},{"issue":"1","key":"813_CR8","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1007\/s00018-024-05484-w","volume":"81","author":"G Tang","year":"2024","unstructured":"Tang G, et al. Neutrophil-centric analysis of gastric cancer: prognostic modeling and molecular insights. Cell Mol Life Sci. 2024;81(1):452.","journal-title":"Cell Mol Life Sci"},{"issue":"21","key":"813_CR9","doi-asserted-by":"publisher","first-page":"12667","DOI":"10.1111\/jcmm.15835","volume":"24","author":"H Feng","year":"2020","unstructured":"Feng H, et al. Identification and validation of critical alternative splicing events and splicing factors in gastric cancer progression. J Cell Mol Med. 2020;24(21):12667\u201380.","journal-title":"J Cell Mol Med"},{"key":"813_CR10","unstructured":"Wang L. The role and mechnism of SRSF10-mediated ATR alternative splicing in gastric cancer [In Chinese]. Fujian Medical University; 2022."},{"issue":"1","key":"813_CR11","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13046-024-02946-8","volume":"43","author":"S Yu","year":"2024","unstructured":"Yu S, et al. MAGOH promotes gastric cancer progression via hnRNPA1 expression inhibition-mediated RON\u2206160\/PI3K\/AKT signaling pathway activation. J Exp Clin Cancer Res. 2024;43(1):32.","journal-title":"J Exp Clin Cancer Res"},{"key":"813_CR12","unstructured":"Li X. Study on the effect of genetic and epigenetic on alternative pre-mRNA splicing of tumor suppessor genes CDH1 and hML1 in gastric cancer. Nanjing University; 2015. [In Chinese]."},{"key":"813_CR13","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1186\/s12885-015-1983-5","volume":"15","author":"XW Li","year":"2015","unstructured":"Li XW, et al. Epigenetic regulation of CDH1 exon 8 alternative splicing in gastric cancer. BMC Cancer. 2015;15:954.","journal-title":"BMC Cancer"},{"issue":"4","key":"813_CR14","doi-asserted-by":"publisher","first-page":"101042831769754","DOI":"10.1177\/1010428317697546","volume":"39","author":"JX Zhao","year":"2017","unstructured":"Zhao JX, et al. Effect of histone modifications on hMLH1 alternative splicing in gastric cancer. Tumour Biol. 2017;39(4):1010428317697546.","journal-title":"Tumour Biol"},{"key":"813_CR15","doi-asserted-by":"crossref","unstructured":"Teles SP, et al. Integrated analysis of structural variation and RNA expression of FGFR2 and its splicing modulator ESRP1 highlight the ESRP1(amp)-FGFR2(norm)-FGFR2-IIIc(high) axis in diffuse gastric cancer. Cancers (Basel). 2019;12(1).","DOI":"10.3390\/cancers12010070"},{"issue":"1","key":"813_CR16","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/s41419-025-07924-2","volume":"16","author":"Y Ma","year":"2025","unstructured":"Ma Y, et al. SPAT inhibits LUAD metastasis by targeting SF1-mediated splicing. Cell Death Dis. 2025;16(1):598.","journal-title":"Cell Death Dis"},{"issue":"3","key":"813_CR17","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.molcel.2016.10.007","volume":"64","author":"H Wu","year":"2016","unstructured":"Wu H, et al. Unusual Processing Generates SPA LncRNAs that Sequester Multiple RNA Binding Proteins. Mol Cell. 2016;64(3):534\u201348.","journal-title":"Mol Cell"},{"key":"813_CR18","doi-asserted-by":"crossref","unstructured":"Wu DR, et al. Opposing roles of miR-294 and MBNL1\/2 in shaping the gene regulatory network of embryonic stem cells. EMBO Rep. 2018;19(6).","DOI":"10.15252\/embr.201745657"},{"key":"813_CR19","unstructured":"Wang X. CircURI1 inhibits metastasis via modulating alternative splicing in gastric cancer [In Chinese]. University of Science and Technology of China; 2021."},{"key":"813_CR20","doi-asserted-by":"crossref","unstructured":"Wang X, et al. CircURI1 interacts with hnRNPM to inhibit metastasis by modulating alternative splicing in gastric cancer. Proc Natl Acad Sci U S A. 2021;118(33).","DOI":"10.1073\/pnas.2012881118"},{"issue":"6","key":"813_CR21","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1007\/s13402-023-00835-4","volume":"46","author":"H Deng","year":"2023","unstructured":"Deng H, et al. LncRNA CCAT2 promotes malignant progression of metastatic gastric cancer through regulating CD44 alternative splicing. Cell Oncol (Dordr). 2023;46(6):1675\u201390.","journal-title":"Cell Oncol (Dordr)"},{"key":"813_CR22","doi-asserted-by":"publisher","first-page":"100728","DOI":"10.1016\/j.drup.2020.100728","volume":"53","author":"R Sciarrillo","year":"2020","unstructured":"Sciarrillo R, et al. The role of alternative splicing in cancer: From oncogenesis to drug resistance. Drug Resist Updat. 2020;53:100728.","journal-title":"Drug Resist Updat"},{"issue":"1","key":"813_CR23","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13046-024-03264-9","volume":"44","author":"G Jin","year":"2025","unstructured":"Jin G, et al. hnRNPU-mediated pathogenic alternative splicing drives gastric cancer progression. J Exp Clin Cancer Res. 2025;44(1):8.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"813_CR24","doi-asserted-by":"publisher","first-page":"17140","DOI":"10.1038\/s41598-024-66678-7","volume":"14","author":"X Chen","year":"2024","unstructured":"Chen X, et al. KPNA2 promotes the progression of gastric cancer by regulating the alternative splicing of related genes. Sci Rep. 2024;14(1):17140.","journal-title":"Sci Rep"},{"issue":"5","key":"813_CR25","doi-asserted-by":"publisher","first-page":"e12484","DOI":"10.1111\/cpr.12484","volume":"51","author":"N Dou","year":"2018","unstructured":"Dou N, et al. SNRPA enhances tumour cell growth in gastric cancer through modulating NGF expression. Cell Prolif. 2018;51(5):e12484.","journal-title":"Cell Prolif"},{"key":"813_CR26","doi-asserted-by":"publisher","first-page":"149682","DOI":"10.1016\/j.gene.2025.149682","volume":"965","author":"L Zhang","year":"2025","unstructured":"Zhang L, et al. SNRPB promotes gastric cancer progression via the ECM receptor signaling pathway. Gene. 2025;965:149682.","journal-title":"Gene"},{"issue":"1","key":"813_CR27","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/s41420-023-01757-8","volume":"9","author":"C Li","year":"2023","unstructured":"Li C, et al. ESRP1-driven alternative splicing of CLSTN1 inhibits the metastasis of gastric cancer. Cell Death Discov. 2023;9(1):464.","journal-title":"Cell Death Discov"},{"issue":"9","key":"813_CR28","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.3724\/SP.J.1008.2009.01004","volume":"30","author":"XK Liu","year":"2009","unstructured":"Liu XK, et al. NR4A2 and its splicing variants contribute to tumorigenesis and metastasis of gastric cancer. Acad J Second Military Med Univ. 2009;30(9):1004\u20138.","journal-title":"Acad J Second Military Med Univ"},{"issue":"21","key":"813_CR29","first-page":"7247","volume":"63","author":"JH Lee","year":"2003","unstructured":"Lee JH, et al. Expression of a splice variant of KAI1, a tumor metastasis suppressor gene, influences tumor invasion and progression. Cancer Res. 2003;63(21):7247\u201355.","journal-title":"Cancer Res"},{"issue":"12","key":"813_CR30","doi-asserted-by":"publisher","first-page":"4235","DOI":"10.1158\/0008-5472.CAN-04-0275","volume":"64","author":"JH Lee","year":"2004","unstructured":"Lee JH, et al. KAI1 COOH-terminal interacting tetraspanin (KITENIN), a member of the tetraspanin family, interacts with KAI1, a tumor metastasis suppressor, and enhances metastasis of cancer. Cancer Res. 2004;64(12):4235\u201343.","journal-title":"Cancer Res"},{"issue":"7","key":"813_CR31","doi-asserted-by":"publisher","first-page":"348","DOI":"10.5483\/BMBRep.2022.55.7.034","volume":"55","author":"A Kim","year":"2022","unstructured":"Kim A, et al. Alternative splicing variant of NRP\/B promotes tumorigenesis of gastric cancer. BMB Rep. 2022;55(7):348\u201353.","journal-title":"BMB Rep"},{"issue":"1","key":"813_CR32","doi-asserted-by":"publisher","first-page":"6274","DOI":"10.1038\/s41467-022-33786-9","volume":"13","author":"J Lee","year":"2022","unstructured":"Lee J, et al. ESRP1-regulated isoform switching of LRRFIP2 determines metastasis of gastric cancer. Nat Commun. 2022;13(1):6274.","journal-title":"Nat Commun"},{"key":"813_CR33","doi-asserted-by":"publisher","first-page":"836199","DOI":"10.3389\/fgene.2022.836199","volume":"13","author":"Y Jin","year":"2022","unstructured":"Jin Y, et al. DEAD-Box Helicase 27 Triggers Epithelial to Mesenchymal Transition by Regulating Alternative Splicing of Lipoma-Preferred Partner in Gastric Cancer Metastasis. Front Genet. 2022;13:836199.","journal-title":"Front Genet"},{"issue":"5","key":"813_CR34","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/s41419-018-0608-8","volume":"9","author":"X Liang","year":"2018","unstructured":"Liang X, et al. PTBP3 contributes to the metastasis of gastric cancer by mediating CAV1 alternative splicing. Cell Death Dis. 2018;9(5):569.","journal-title":"Cell Death Dis"},{"issue":"11","key":"813_CR35","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/s41419-022-05436-x","volume":"13","author":"Q He","year":"2022","unstructured":"He Q, et al. LINC00924-induced fatty acid metabolic reprogramming facilitates gastric cancer peritoneal metastasis via hnRNPC-regulated alternative splicing of Mnk2. Cell Death Dis. 2022;13(11):987.","journal-title":"Cell Death Dis"},{"issue":"21","key":"813_CR36","doi-asserted-by":"publisher","first-page":"e2415983","DOI":"10.1002\/advs.202415983","volume":"12","author":"Y Zhou","year":"2025","unstructured":"Zhou Y, et al. Targeting PTBP3-Mediated Alternative Splicing of COX11 Induces Cuproptosis for Inhibiting Gastric Cancer Peritoneal Metastasis. Adv Sci (Weinh). 2025;12(21):e2415983.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"813_CR37","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12943-020-01299-y","volume":"20","author":"F Zhang","year":"2021","unstructured":"Zhang F, et al. LncRNA CRNDE attenuates chemoresistance in gastric cancer via SRSF6-regulated alternative splicing of PICALM. Mol Cancer. 2021;20(1):6.","journal-title":"Mol Cancer"},{"issue":"4","key":"813_CR38","first-page":"201","volume":"26","author":"F Yin","year":"2004","unstructured":"Yin F, et al. [Multidrug resistant effect of alternative splicing form of MAD2 gene-MAD2beta on human gastric cancer cell]. Zhonghua Zhong Liu Za Zhi. 2004;26(4):201\u20134.","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"issue":"12","key":"813_CR39","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/j.lfs.2005.06.034","volume":"78","author":"F Yin","year":"2006","unstructured":"Yin F, et al. Mad2beta, an alternative variant of Mad2 reducing mitotic arrest and apoptosis induced by adriamycin in gastric cancer cells. Life Sci. 2006;78(12):1277\u201386.","journal-title":"Life Sci"},{"issue":"9","key":"813_CR40","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1002\/onco.13799","volume":"26","author":"XD Jiao","year":"2021","unstructured":"Jiao XD, et al. HER2 Splice Site Mutation c.1899-1G\u2009>\u2009A as the Potential Acquired Resistance to Trastuzumab in a Patient with HER2-Positive Gastric Adenocarcinoma. Oncologist. 2021;26(9):717\u201321.","journal-title":"Oncologist"},{"issue":"5","key":"813_CR41","first-page":"1591","volume":"54","author":"J Li","year":"2019","unstructured":"Li J, Isoforms S, et al. L of MRPL33 from alternative splicing have isoform\u2013specific roles in the chemoresponse to epirubicin in gastric cancer cells via the PI3K\/AKT signaling pathway. Int J Oncol. 2019;54(5):1591\u2013600.","journal-title":"Int J Oncol"},{"key":"813_CR42","doi-asserted-by":"publisher","first-page":"28222","DOI":"10.1038\/srep28222","volume":"6","author":"H Yong","year":"2016","unstructured":"Yong H, et al. Prognostic value of decreased expression of RBM4 in human gastric cancer. Sci Rep. 2016;6:28222.","journal-title":"Sci Rep"},{"issue":"1","key":"813_CR43","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1159\/000178152","volume":"76","author":"JH Xu","year":"2009","unstructured":"Xu JH, et al. Changes of the alternative splicing variants of human telomerase reverse transcriptase during gastric carcinogenesis. Pathobiology. 2009;76(1):23\u20139.","journal-title":"Pathobiology"},{"key":"813_CR44","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ebiom.2018.07.040","volume":"34","author":"P Lin","year":"2018","unstructured":"Lin P, et al. Systematic Analysis of Survival-Associated Alternative Splicing Signatures in Gastrointestinal Pan-Adenocarcinomas. EBioMedicine. 2018;34:46\u201360.","journal-title":"EBioMedicine"},{"key":"813_CR45","doi-asserted-by":"publisher","first-page":"e9174","DOI":"10.7717\/peerj.9174","volume":"8","author":"J Liu","year":"2020","unstructured":"Liu J, et al. Identification of potential biomarkers and their clinical significance in gastric cancer using bioinformatics analysis methods. PeerJ. 2020;8:e9174.","journal-title":"PeerJ"},{"key":"813_CR46","doi-asserted-by":"publisher","first-page":"1670526","DOI":"10.3389\/fonc.2025.1670526","volume":"15","author":"D Elihamu","year":"2025","unstructured":"Elihamu D, et al. CORO1A: a pan-cancer prognosis, diagnostic and immune biomarker based on breast cancer validation. Front Oncol. 2025;15:1670526.","journal-title":"Front Oncol"},{"key":"813_CR47","first-page":"1439","volume":"17","author":"Y Gou","year":"2025","unstructured":"Gou Y, et al. Integrated Pan-Cancer Profiling and Breast Cancer Validation Identify BEND3 as a Potential Prognostic and Immune Biomarker. Breast Cancer (Dove Med Press). 2025;17:1439\u201361.","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"813_CR48","doi-asserted-by":"publisher","first-page":"1667589","DOI":"10.3389\/fonc.2025.1667589","volume":"15","author":"J Wang","year":"2025","unstructured":"Wang J, et al. CLIC6\u2019s role in cancer: from broad analysis to breast cancer validation. Front Oncol. 2025;15:1667589.","journal-title":"Front Oncol"},{"key":"813_CR49","doi-asserted-by":"publisher","first-page":"1770711","DOI":"10.3389\/fimmu.2026.1770711","volume":"17","author":"Y Wang","year":"2026","unstructured":"Wang Y, et al. The value of Protein Phosphatase Methylesterase 1 in diagnosis, prognosis and immunoregulation: from pan-cancer analysis to breast cancer verification. Front Immunol. 2026;17:1770711.","journal-title":"Front Immunol"},{"key":"813_CR50","doi-asserted-by":"crossref","unstructured":"Wu YY, et al. A multi-omics prognostic model of cuproptosis affects the prognosis of stomach adenocarcinoma. Clin Epigenetics. 2025;17(1).","DOI":"10.1186\/s13148-025-01894-0"},{"issue":"1","key":"813_CR51","first-page":"1","volume":"47","author":"Y Li-Xia","year":"2025","unstructured":"Li-Xia Y, et al. Expression Level of Small Nuclear Ribonucleoprotein D1 in Gastric Cancer and Its Effect on Prognosis. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2025;47(1):1\u20139.","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"issue":"1","key":"813_CR52","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13046-025-03278-x","volume":"44","author":"B Bao","year":"2025","unstructured":"Bao B, et al. SNORA37\/CMTR1\/ELAVL1 feedback loop drives gastric cancer progression via facilitating CD44 alternative splicing. J Exp Clin Cancer Res. 2025;44(1):15.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"813_CR53","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s12935-021-01968-y","volume":"21","author":"WZ Peng","year":"2021","unstructured":"Peng WZ, et al. hnRNPA2B1 regulates the alternative splicing of BIRC5 to promote gastric cancer progression. Cancer Cell Int. 2021;21(1):281.","journal-title":"Cancer Cell Int"},{"key":"813_CR54","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1186\/s12935-019-1020-x","volume":"19","author":"WZ Peng","year":"2019","unstructured":"Peng WZ, et al. hnRNPK promotes gastric tumorigenesis through regulating CD44E alternative splicing. Cancer Cell Int. 2019;19:335.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"813_CR55","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ajpath.2023.10.007","volume":"194","author":"YY Dong","year":"2024","unstructured":"Dong YY, et al. Alternative Splicing Factor Heterogeneous Nuclear Ribonucleoprotein U as a Promising Biomarker for Gastric Cancer Risk and Prognosis with Tumor-Promoting Properties. Am J Pathol. 2024;194(1):13\u201329.","journal-title":"Am J Pathol"},{"issue":"11","key":"813_CR56","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1007\/s11010-023-04905-x","volume":"479","author":"Q Yu","year":"2024","unstructured":"Yu Q, et al. PTBP1 as a potential regulator of disease. Mol Cell Biochem. 2024;479(11):2875\u201394.","journal-title":"Mol Cell Biochem"},{"key":"813_CR57","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.3389\/fonc.2020.01477","volume":"10","author":"B Chen","year":"2020","unstructured":"Chen B, et al. PTBP3 Induced Inhibition of Differentiation of Gastric Cancer Cells Through Alternative Splicing of Id1. Front Oncol. 2020;10:1477.","journal-title":"Front Oncol"},{"key":"813_CR58","doi-asserted-by":"crossref","unstructured":"Lu CP, et al. RNA-binding motif protein RBM39 enhances the proliferation of gastric cancer cells by facilitating an oncogenic splicing switch in MRPL33. Acta Pharmacol Sin. 2025.","DOI":"10.1038\/s41401-024-01431-4"},{"issue":"2","key":"813_CR59","doi-asserted-by":"publisher","first-page":"798","DOI":"10.3892\/etm.2021.10230","volume":"22","author":"D Zhou","year":"2021","unstructured":"Zhou D, et al. The effect of splicing MST1R in gastric cancer was enhanced by lncRNA FENDRR. Exp Ther Med. 2021;22(2):798.","journal-title":"Exp Ther Med"},{"key":"813_CR60","unstructured":"Zhang P. Mechanism of PFKFB3 mediated peritoneal metastasis of gastric cancer by phosphorylating SRSF5 [In Chinese]. Southern Medical University; 2023."},{"issue":"5","key":"813_CR61","doi-asserted-by":"publisher","first-page":"S526","DOI":"10.1016\/S0016-5085(13)61956-3","volume":"144","author":"S Zhu","year":"2013","unstructured":"Zhu S, et al. Regulation of splicing of CD44 by DARPP-32 in gastric cancers. Gastroenterology. 2013;144(5):S526\u20137.","journal-title":"Gastroenterology"},{"issue":"14","key":"813_CR62","doi-asserted-by":"publisher","first-page":"e34381","DOI":"10.1016\/j.heliyon.2024.e34381","volume":"10","author":"G Long","year":"2024","unstructured":"Long G, et al. Ferroptosis-related alternative splicing signatures as potential biomarkers for predicting prognosis and therapy response in gastric cancer. Heliyon. 2024;10(14):e34381.","journal-title":"Heliyon"},{"issue":"8","key":"813_CR63","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.3748\/wjg.v22.i8.2475","volume":"22","author":"MS Ur Rahman","year":"2016","unstructured":"Ur Rahman MS, Cao J. Estrogen receptors in gastric cancer: Advances and perspectives. World J Gastroenterol. 2016;22(8):2475\u201382.","journal-title":"World J Gastroenterol"},{"issue":"6","key":"813_CR64","doi-asserted-by":"publisher","first-page":"505","DOI":"10.3346\/jkms.1997.12.6.505","volume":"12","author":"YS Kim","year":"1997","unstructured":"Kim YS, et al. Molecular genetic characterization of alternatively spliced CD44 transcripts in human stomach carcinoma. J Korean Med Sci. 1997;12(6):505\u201313.","journal-title":"J Korean Med Sci"},{"issue":"2","key":"813_CR65","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1136\/mp.50.2.57","volume":"50","author":"Z Rudzki","year":"1997","unstructured":"Rudzki Z. CD44 and the adhesion of neoplastic cells. J Clin Pathol - Mol Pathol. 1997;50(2):57\u201371.","journal-title":"J Clin Pathol - Mol Pathol"},{"issue":"5","key":"813_CR66","first-page":"343","volume":"17","author":"H Li","year":"2000","unstructured":"Li H, et al. [Alternative splicing of RHAMM gene in chinese gastric cancers and its in vitro regulation]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2000;17(5):343\u20137.","journal-title":"Zhonghua Yi Xue Yi Chuan Xue Za Zhi"},{"issue":"9","key":"813_CR67","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.4251\/wjgo.v14.i9.1637","volume":"14","author":"AR Alnuaimi","year":"2022","unstructured":"Alnuaimi AR, et al. Emerging role of caldesmon in cancer: A potential biomarker for colorectal cancer and other cancers. World J Gastrointest Oncol. 2022;14(9):1637\u201353.","journal-title":"World J Gastrointest Oncol"},{"issue":"4","key":"813_CR68","doi-asserted-by":"publisher","first-page":"626","DOI":"10.2741\/4609","volume":"23","author":"T Ishiwata","year":"2018","unstructured":"Ishiwata T. Role of fibroblast growth factor receptor-2 splicing in normal and cancer cells. Front Biosci (Landmark Ed). 2018;23(4):626\u201339.","journal-title":"Front Biosci (Landmark Ed)"},{"key":"813_CR69","unstructured":"Li Y. Modification of Mcl-1 Alternative Splicing Using Steric-Blocking Oligonucleoides Induces Apoptosis in Gastric Cancer [In Chinese]. Lanzhou University; 2020."},{"key":"813_CR70","doi-asserted-by":"crossref","unstructured":"Kitamura K, et al. The Link of mRNA and rRNA transcription by PUF60\/FIR through TFIIH\/P62 as a novel therapeutic target for cancer. Int J Mol Sci. 2023;24(24).","DOI":"10.3390\/ijms242417341"},{"issue":"1","key":"813_CR71","doi-asserted-by":"publisher","first-page":"4930","DOI":"10.1038\/s41598-017-05247-7","volume":"7","author":"ES Choi","year":"2017","unstructured":"Choi ES, et al. CD44v8-10 as a potential theranostic biomarker for targeting disseminated cancer cells in advanced gastric cancer. Sci Rep. 2017;7(1):4930.","journal-title":"Sci Rep"},{"issue":"11","key":"813_CR72","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1038\/embor.2008.189","volume":"9","author":"AR Grosso","year":"2008","unstructured":"Grosso AR, Martins S, Carmo-Fonseca M. The emerging role of splicing factors in cancer. EMBO Rep. 2008;9(11):1087\u201393.","journal-title":"EMBO Rep"},{"key":"813_CR73","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/978-3-030-38315-2_7","volume":"1240","author":"CP Chang","year":"2020","unstructured":"Chang CP, et al. ST2 Signaling in the Tumor Microenvironment. Adv Exp Med Biol. 2020;1240:83\u201393.","journal-title":"Adv Exp Med Biol"},{"issue":"9","key":"813_CR74","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1038\/s41418-021-00779-y","volume":"28","author":"L Yang","year":"2021","unstructured":"Yang L, et al. miR-4646-5p promotes gastric cancer metastasis by regulating ABHD16A and metabolite lysophosphatidylserines. Cell Death Differ. 2021;28(9):2708\u201327.","journal-title":"Cell Death Differ"},{"issue":"4","key":"813_CR75","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1158\/0008-5472.CAN-21-2117","volume":"82","author":"Y Jun","year":"2022","unstructured":"Jun Y, et al. Comprehensive Analysis of Alternative Splicing in Gastric Cancer Identifies Epithelial-Mesenchymal Transition Subtypes Associated with Survival. Cancer Res. 2022;82(4):543\u201355.","journal-title":"Cancer Res"},{"issue":"3","key":"813_CR76","first-page":"440","volume":"21","author":"J Zhou","year":"2004","unstructured":"Zhou J, et al. [Human gastric tissues coexpress two different splicing cholecystokinin-B\/gastrin receptors]. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2004;21(3):440\u20133.","journal-title":"Sheng Wu Yi Xue Gong Cheng Xue Za Zhi"},{"key":"813_CR77","doi-asserted-by":"publisher","first-page":"640272","DOI":"10.3389\/fonc.2021.640272","volume":"11","author":"J Zhang","year":"2021","unstructured":"Zhang J, Goel A, Zhu L. Identification of Novel Alternative Splicing Events Associated With Tumorigenesis, Protein Modification, and Immune Microenvironment in Early-Onset Gastric Cancer. Front Oncol. 2021;11:640272.","journal-title":"Front Oncol"},{"key":"813_CR78","doi-asserted-by":"crossref","unstructured":"Zhong B, et al. Landscape of splicing factors in early-onset gastric cancer reveals SRSF1 as a key driver of oxaliplatin resistance. J Biol Chem. 2026;302(4).","DOI":"10.1016\/j.jbc.2026.111279"},{"key":"813_CR79","doi-asserted-by":"crossref","unstructured":"Jiang KC, et al. PD-L1 splice variant-driven soluble PD-L1 secretion promotes immune evasion in gastric cancer. Int J Biol Macromol. 2025;334.","DOI":"10.1016\/j.ijbiomac.2025.149135"},{"issue":"1","key":"813_CR80","doi-asserted-by":"publisher","first-page":"16","DOI":"10.5230\/jgc.2026.26.e12","volume":"26","author":"JS Lee","year":"2026","unstructured":"Lee JS. Evolving Molecular Subtypes of Gastric Cancer: From Past Classifications to Present Consensus and Future Directions for Precision Therapy. J Gastric Cancer. 2026;26(1):16\u201330.","journal-title":"J Gastric Cancer"},{"issue":"8","key":"813_CR81","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.molcel.2023.03.001","volume":"83","author":"R Ye","year":"2023","unstructured":"Ye R, et al. Capture RIC-seq reveals positional rules of PTBP1-associated RNA loops in splicing regulation. Mol Cell. 2023;83(8):1311\u2013e13277.","journal-title":"Mol Cell"},{"issue":"1","key":"813_CR82","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/s41597-023-02429-z","volume":"10","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, et al. Structure prediction of novel isoforms from uveal melanoma by AlphaFold. Sci Data. 2023;10(1):513.","journal-title":"Sci Data"},{"issue":"D1","key":"813_CR83","doi-asserted-by":"publisher","first-page":"D1196","DOI":"10.1093\/nar\/gkac955","volume":"51","author":"S Wu","year":"2023","unstructured":"Wu S, et al. ASCancer Atlas: a comprehensive knowledgebase of alternative splicing in human cancers. Nucleic Acids Res. 2023;51(D1):D1196\u2013204.","journal-title":"Nucleic Acids Res"}],"container-title":["Biology Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13062-026-00813-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00813-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00813-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T04:08:16Z","timestamp":1781064496000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13062-026-00813-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["813"],"URL":"https:\/\/doi.org\/10.1186\/s13062-026-00813-4","relation":{},"ISSN":["1745-6150"],"issn-type":[{"value":"1745-6150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]},"assertion":[{"value":"17 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"97"}}